Advances in radioligand theranostics in oncology
| dc.contributor.author | Lawal, Ismaheel Opeyemi | |
| dc.contributor.author | Abubakar, Sofiullah O. | |
| dc.contributor.author | Ndlovu, Honest | |
| dc.contributor.author | Mokoala, Kgomotso M.G. | |
| dc.contributor.author | More, Stuart | |
| dc.contributor.author | Sathekge, Mike Machaba | |
| dc.date.accessioned | 2024-06-19T09:33:03Z | |
| dc.date.issued | 2024-05 | |
| dc.description.abstract | Please read abstract in the article. | en_US |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.embargo | 2025-03-31 | |
| dc.description.librarian | hj2024 | en_US |
| dc.description.sdg | SDG-03:Good heatlh and well-being | en_US |
| dc.description.uri | https://link.springer.com/journal/40291 | en_US |
| dc.identifier.citation | Lawal, I.O., Abubakar, S.O., Ndlovu, H. et al. Advances in Radioligand Theranostics in Oncology. Molecular Diagnosis & Therapy 28, 265–289 (2024). https://doi.org/10.1007/s40291-024-00702-4. | en_US |
| dc.identifier.issn | 1177-1062 (print) | |
| dc.identifier.issn | 1179-2000 (online) | |
| dc.identifier.other | 10.1007/s40291-024-00702-4 | |
| dc.identifier.uri | http://hdl.handle.net/2263/96534 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.rights | © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2024. The original publication is available at : https://link.springer.com/journal/40291. | en_US |
| dc.subject | Lutetium-177 DOTATATE (177Lu-DOTATATE) | en_US |
| dc.subject | Lutetium-177 prostate-specific membrane antigen (177Lu-PSMA) | en_US |
| dc.subject | Fibroblast activation protein (FAP) | en_US |
| dc.subject | Chemokine receptor 4 (CXCR4) | en_US |
| dc.subject | Radioligand | en_US |
| dc.subject | Theranostics | en_US |
| dc.subject | Oncology | en_US |
| dc.subject | SDG-03: Good health and well-being | en_US |
| dc.title | Advances in radioligand theranostics in oncology | en_US |
| dc.type | Postprint Article | en_US |